ClinicalTrials.gg
Status unknownNCT06620445Updated Oct 1, 2024

Efficacy of Psychological Intervention for Children With Cancer

An interventional study of Interventiion or CBT Group in Clinical Depression, Clinical Anxiety and Quality of Life, sponsored by Pakistan Institute of Medical Sciences. Status unknown at 1 site in Pakistan. Open to participants aged 8 Years to 16 Years. Per ClinicalTrials.gov, last updated 2024-10-01.

Sponsored by Pakistan Institute of Medical Sciences · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Sep 2024), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
8 Years to 16 Years
Sex
All
01

Study summary

The study will be conductued at the Pediatric Oncology Department of the Children's Hospital, PIMS Islamabad, over the peroid of six months. This single-blinded, two-arm RCT study will involve 80 children aged 8 to 16 years with maligancies recieving chemotherapy. Participants will be randomly allocated to either interventional or CBT group which will recieve weekly five sessions of Cognitive Behaviour Therapy (CBT) or the control group, which will recieve the usual care. CBT session will be contducted by Clinical Psychologist will last 30-35 minutes. Outcomes will be measured at Baseine and one month post intervention using Revised Child Anxiety and Depression Scale (RCADS) and Pediatric Quality of Life Generic Core Score 4.0.

Read the detailed description

Background:

Children with cancer and their families experience various psychosocial challenges during and after treatment, including physical and cognitive changes due to medical treatment, alterations in social and familial roles, and the potential threat of death.

While most children and families cope and adjust well to the diagnosis and treatment of cancer, a subset of children is at increased risk for anxiety, depression, educational, and relationship difficulties. Caregivers and siblings of pediatric patients are also at risk for heightened distress and post-traumatic stress. Psychosocial care and interventions can play an important role in supporting the well-being of the entire family, beginning at diagnosis.

The psychological impact of cancer on Pakistani children is diverse and far-reaching, ranging from concerns about their future to worries about appearing different from their peers. Given the high prevalence of psychological difficulties among pediatric cancer patients in Pakistan, it is essential to determine the effectiveness of interventions offered to support their mental health and well-being. Studies on cancer patients related to their psychiatric problems are already rare in Pakistan.

Objective:

The main objective of this study is to compare the effect of psychological intervention, such as cognitive-behavioral therapy (CBT), to the routine care given among pediatric oncology patients. The findings of this study will provide evidence to support the integration of psychological intervention strategies into pediatric oncology practice, thus adding new knowledge to the literature and helping improve the care of children with malignancies receiving chemotherapy.

Study Design:

The study will be conducted at the Pediatric Oncology Unit, PIMS, Islamabad. This study will be a two-armed longitudinal, randomized control trial expected to run for six months. Children with malignancy receiving chemotherapy will be recruited and randomly assigned to experimental or control groups.

Intervention:

The experimental group will receive five sessions of cognitive-behavioral intervention, where maladaptive thoughts and behavior will be identified, behavioral activation will be encouraged, and deep breathing exercises will be practiced. The control group will receive the usual care.

Recruitment and Sample:

The recruitment process will involve the random selection of children diagnosed with malignancies and undergoing treatment at the Pediatric Oncology Unit, the Children's Hospital PIMS Islamabad, Pakistan.

Outcome Measures:

The outcomes will be measured at baseline, post-intervention, and one month after the intervention using the Revised Child Anxiety and Depression Scale and Pediatric Quality of Life Inventory Generic Core Score 4.0.

Data Analysis:

Data analysis will be conducted using SPSS version 23.

Ethical Considerations:

Permission to conduct the study will be acquired from the Ethical Review Board (ERB) of PIMS Islamabad.

02

Conditions studied

  • Clinical Depression
  • Clinical Anxiety
  • Quality of Life

Keywords

  • Psychological Intervention
  • Pediatric Cancer
03

In context

Depressive Disorder, Major

2,805 studies on the registry are indexed under Depressive Disorder, Major; 565 are open to participants now.

This study's planned enrollment of 80 is close to the median of 80 across 2,338 interventional studies indexed under Depressive Disorder, Major.

Browse Depressive Disorder, Major studies →

Lead sponsor

Pakistan Institute of Medical Sciences is the lead sponsor of 54 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Eligibility Criteria:

Inclusion Criteria:

  1. Children aged 16-18 years
  2. Diagnosed with malignancy
  3. Recieving chemotherapy at the Pediatric Oncology Department of PIMS Islamabad
  4. Able to understand and participate in CBT sessions
  5. Parent/Caregiver consent and child assent

Exlusion Criteria:

  1. Children with severe cognitive impairment or intellectual disability
  2. Children with a comorbid medical conditions
  3. Children whose parents or caregivers are unable to provide consent
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Interventional Group

    The Intervention or CBT group included 40 children aged 8-16 years with malignancies recieving chemotherapy. They will recieve weekly five sessions of CBT (30-35 minutes per session)

    Behavioral: Interventiion or CBT Group

  • No intervention
    Control or Usual Care Group

    The Control or No Intervention Group also known as Comparision Group or Usual Group will recieve the standard care or usual care for their condition. It will serve as a baseline for the CBT or Intervention Group.

Interventions

  • BehavioralInterventiion or CBT Group

    This RCT aims to evaluate the effect of Cognitive Behavioral Therapy (CBT) compared to usual care (UC) in pediatric oncology patients. We hypothesize that those receiving CBT will report lower depression and anxiety and improved QoL six months post-enrollment.

    Also known as: Cognitive or Pschological Intervention

06

What researchers measure

Primary outcomes

  1. Revised Child Anxiety and Depression Scale (RCADS)

    The RCADS is a standardized, self reported scale measuring anxiety and depression symptoms among children aged 8-18 years.

    Time frame: Baseline (before the intervention) and one month post intervention (after the five weekly sessions of CBT)

Secondary outcomes

  1. Pediatric QoL

    It evaluates physical, emotional, social and school funtioning.

    Time frame: Baseline and one month post intervention

07

Study locations

1 site
08

References and documents

Study documents

  • Study protocol · Sep 9, 2024
  • Statistical analysis plan · Aug 14, 2024
  • Informed consent form · Aug 14, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — Demographic, Clinical and Treatment related Information of the Participants

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06620445
Lead sponsor
Pakistan Institute of Medical Sciences
Responsible party
Dr. Muhammad Wasim Khan (Dr. Muhammad Wasim Khan, Pakistan Institute of Medical Sciences) — Principal investigator
First posted
Oct 1, 2024
Start date
Oct 10, 2024 (estimated)
Primary completion
Feb 10, 2025 (estimated)
Completion
Jun 30, 2025 (estimated)
Last update
Oct 1, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion